LEADERSHIP
Jennifer A. Johnston, PhD
Cofounder and CEO
David Weiner
Head of Clinical Affairs
Sarah Finley
Project Management
Lisa D. Beilke, PhD
Head of Toxicology
George Tonn
Head of DMPK
Paul Fatheree
Head of Chemistry
At FinsnoBio we are dedicated to bringing precisions medicines to patients with serious medical conditions.
Our core team of industry professionals and network of academic experts are working together to deliver on on the scope of therapeutic potential for genetic targets in neurodegeneration.